Online Only Articles

NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors

CHU Lille, Biology and Pathology Center, Laboratory of Hematology, Lille, France;INSERM UMR-S 1172, Cancer Research Institute, Lille, France
CHU Lille, Biology and Pathology Center, Laboratory of Hematology, Lille, France
CHU Lille, Biology and Pathology Center, Laboratory of Hematology, Lille, France
CHU Lille, Jeanne de Flandre Hospital, Pediatric Hematology Department, Lille, France
CHU Lille, Biology and Pathology Center, Laboratory of Hematology, Lille, France
CHU Lille, Biology and Pathology Center, Laboratory of Hematology, Lille, France;INSERM UMR-S 1172, Cancer Research Institute, Lille, France
CHU Lille, Jeanne de Flandre Hospital, Pediatric Hematology Department, Lille, France
CHU Lille, Jeanne de Flandre Hospital, Pediatric Hematology Department, Lille, France
CHU Lille, Jeanne de Flandre Hospital, Pediatric Hematology Department, Lille, France
Assistance Publique-Hôpitaux de Paris, Saint Louis Hospital, Laboratory of Hematology, Paris, France
CHU Lille, Biology and Pathology Center, Laboratory of Hematology, Lille, France;INSERM UMR-S 1172, Cancer Research Institute, Lille, France
Vol. 101 No. 4 (2016): April, 2016 https://doi.org/10.3324/haematol.2015.136499